Loading provider…
Loading provider…
Medical Oncology Physician in Wyoming, MI
NPI: 1417153701Primary Practice Location
UNIVERSITY OF MICHIGAN HEALTH - WEST
5900 Byron Center Ave Sw, Wyoming, MI
Primary Employer
Metropolitan Hospital
uofmhealthwest.org
HQ Phone
Get M.D. Ben's Phone NumberMobile
Get M.D. Ben's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
MI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 177 | 346 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 85 | 102 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 69 | 160 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 51 | 55 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 46 | 110 |
Lead Sponsor: Veru Inc.
Intervention / Treatment: DRUG: Exemestane, DRUG: Enobosarm
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Pembrolizumab, DRUG: Pemetrexed, OTHER: Comprehensive Geriatric Assessment
Lead Sponsor: Alliance Foundation Trials, LLC.
Collaborators: Pfizer, Syneos Health, GBG Forschungs GmbH, UNICANCER, Fondazione Michelangelo, PrECOG, LLC., Breast Cancer Trials, Australia and New Zealand, SOLTI Breast Cancer Research Group
Intervention / Treatment: DRUG: Exemestane, DRUG: Fulvestrant, DRUG: Anastrozole, DRUG: letrozole, DRUG: trastuzumab, DRUG: palbociclib, DRUG: pertuzumab